Nearly 400 trials and Belgium’s isotope hub signal rapid clinical diversification for radioligand therapy — but policy, ...
While RMC is resistant to many common treatments, specific protocols have shown efficacy. Platinum-based chemotherapy remains ...
Even as therapies improve, a startling number of cancer patients are not getting genomic tests that could improve their chance of survival.
Photodynamic treatment of cancer is based on administering an initially inactive substance that is only activated in the ...
Despite major advances in targeted therapy, chronic lymphocytic leukemia (CLL) remains largely incurable. Resistance to ...
Discover how advanced radiation and targeted therapies are transforming nasopharyngeal cancer care in India. Expert insights ...
New findings from VCU Massey Comprehensive Cancer Center and the VCU Institute of Molecular Medicine (VIMM), published in ...
Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi” or the “Company”), a biotechnology company pioneering the development of targeted genetic medicines, will present new data at the American ...
WELLINGTON, New Zealand and KINGSTON, Ontario, April 07, 2026 (GLOBE NEWSWIRE) -- BioOra Limited ("BioOra"), a commercial-stage cell therapy company advancing CAR-T therapies for cancer patients, and ...
Immunotherapy and targeted therapy are often the first lines of treatment for advanced kidney cancer, with surgery and ...
Targeted liposomal nanoparticles successfully cross the blood brain barrier to treat glioblastoma and doubled survival rates ...
India, April 2 -- Men with early-stage metastatic prostate cancer may soon be able to postpone the debilitating side effects ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results